T cell receptor variable regions in diabetes bind to each other, to insulin, glucagon or insulin receptor, and to their antibodies

Open Autoimmunity Journal

Volumn 4, Issue 1, 2012, Pages 10-22

  Root Bernstein, Robert ^a   Podufaly, Abigail ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Antibody antibody antiidio typy; Antibody TCR antiidiotypy; Antigenic complementarity; Comple mentary TCR; Complementary antibodies; Complementary antigens; Complementary BCR; Diabetes; Glucagon; Glucagon antibody; Glucagon receptor; Insulin; Insulin antibody; Insulin re ceptor antibody; Insulin receptor; Islet cell antigen; Molecular mimicry; PTP IA 2; T cell receptor cross reactivity; TCR TCR antiidiotypy

Indexed keywords

GLUCAGON; GLUCAGON ANTIBODY; GLUCAGON RECEPTOR; INSULIN; INSULIN RECEPTOR; T LYMPHOCYTE RECEPTOR;

ANTIBODY AFFINITY; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; COMPLEMENT INHIBITION; CONTROLLED STUDY; CROSS REACTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; SEQUENCE ANALYSIS; ULTRAVIOLET SPECTROSCOPY;

EID: 84873845883     PISSN: None     EISSN: 18768946     Source Type: Journal    
DOI: 10.2174/1876894601204010010     Document Type: Article

References (61)

1. Griffin A, Zhao CW, Wegmann KW, Hickley WF. Experimental autoimmune insulitis: induction by T lymphocytes specific for a peptide of proinsulin. Am J Pathol 1995; 147(3): 845-57.
2. Schloot NC, Willemen S, Duinkerken G, de Vries RR, Roep BO. Cloned T cells from a recent onset IDDM patient reactive with in-sulin B-chain. J Autoimmun 1998; 11(2): 169-75.
3. Narendran P, Williams AJ, Elsegood K, Leech NJ, Dayan CM. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes. Diabetes Metab Res Rev 2003; 19(1): 52-9.
4. Kent SC, Chen Y, Bregoll L, et al. Expanded T cells from pancre-atic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 2005; 435: 224-8.
5. Nakayama M, Abiru N, Moriyama H, et al. Prime role for an insu-lin epitope in the development of type 1 diabetes in NOD mice. Na-ture 2005; 435(7039): 220-3.
6. Nakayama M, Beilke JN, Jasinski JM, et al. Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity. J Clin Invest 2007; 117(7): 1835-43.
7. Pinkse GG, Tysma OH, Bergen CA, et al. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc Natl Acad Sci USA 2005; 102(51): 18425-30.
8. Pinkse GG, Boitard C, Tree TI, Peakman M, Roep BO. HLA class I epitope discovery in type 1 diabetes: independent and reproduci-ble identification of proinsulin epitopes of CD8 T cells--report of the IDS T Cell Workshop Committee. Ann NY Acad Sci 2006; 1079: 19-23.
9. Jarchum I, Baker JC, Yamada T, et al. In vivo cytotoxicity of insu-lin-specific CD8+ T-cells in HLA-A*0201 transgenic NOD mice. Diabetes 2007; 56(10): 2551-60.
10. Rabin DU, Pleasic SM, Shapiro JA, et al. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phos-phatases. J Immunol 1994; 152: 3183-8.
11. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E. Identi-fication of protein tyrosine phosphotase-like IA-2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol 1995; 155: 5419-26.
12. Solimena M, Dirkx R Jr, Hermel J-M, et al. ICA 512, an autoanti-gen of type I diabetes, is an intrinsic membrane protein of neurose-cretory granules. EMBO J 1996; 15: 2102-14.
13. Honeyman MC, Stone NL, Harrison LC. T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: Potential for mim-icry with rotavirus and other environmental agents. Mol Med 1998; 4: 2331-39.
14. Batarseh H, Thompson RA, Odugbesan O, Barnett AH. Insulin receptor antibodies in diabetes mellitus. Clin Exp Immunol 1988; 71(1): 85-90.
15. Blackard WG, Anderson JH, Mullinax F. Anti-Insulin receptor antibodies and diabetes. Ann Intern Med 1977; 86: 584-5.
16. Elias D, Cohen IR, Schechter Y, Spirer Z, Golander A. Antibodies to insulin receptor followed by anti-idiotype antibodies to insulin in child with hypoglycemia. Diabetes 1987; 36: 348-54.
17. Fonseca V, Khokher MA, Dandona P. Insulin receptor antibodies causing steroid responsive diabetes mellitus in a patient with my-ositis. Br Med J (Clin Res Ed) 1984; 288(6430): 1578.
18. Maron R, Elias D, de Jongh BM, et al. Autoantibodies to the insu-lin receptor in juvenile onset insulin-dependent diabetes. Nature 1983; 303: 817-8.
19. Baker FJ, Lee M, Chien Y-H, Davis MM. Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice. Proc Natl Acad Sci USA 2002; 99(14): 9374-9.
20. Tikochinski Y, Elias D, Steeg C, et al. A shared TCR CDR3 se-quence in NOD mouse autoimmune diabetes. Int Immunol 1999; 11(6): 951-6.
21. Simone E, Daniel D, Schloot N, et al. T cell receptor restriction of diabetogenic autoimmune NOD T cells. Proc Natl Acad Sci USA 1997; 94: 2518-21.
22. Galley KA, Danska JS. Per-islet infiltrates of young non-obese diabetic mice display restricted TCR beta-chain diversity. J Immunol 1995; 154: 2969-82.
23. Durinovic-Bello I, Steinle A, Ziegler AG, Schendel DJ. HLA-DQ-restricted, islet-specific T-cell clones of a type I diabetic patient: T-cell receptor sequence similarities to insulitis-inducing T-cells of nonobese diabetic mice. Diabetes 1994; 43: 1318-25.
24. Candeias S, Katz J, Benoist C, Mathis D, Haskins K. Islet-specific T-cell clones from nonobese diabetic mice express heterogeneous T-cell receptors. Proc Natl Acad Sci USA 1991; 88: 6167-70.
25. Root-Bernstein R. Autoreactive T-cell receptor (Vß/D/Jß) se-quences in diabetes are homologous to insulin, glucagon, the insu-lin receptor, and the glucagon receptor. J Mol Recognit 2009; 22: 177-87.
26. Root-Bernstein R. Molecular complementarity III. Molecular com-plementarity as the basis for peptide hormone evolution: a bioin-formatic case study of insulin, glucagon, and gastrin. J Theor Biol 2002; 218: 71-84.
27. Root-Bernstein R. Peptide self-aggregation and peptide comple-mentarity as bases for the evolution of peptide receptors: a review. J Mol Recogn 2005; 18: 40-9.
28. Root-Bernstein RS, Vonck J. Glucose binds to the insulin receptor affecting the mutual affinity of insulin for its receptor. Cell Mol Life Sci 2009; 66(16): 2721-32.
29. Root-Bernstein RS, Dobbelstein C. Insulin binds to glucagon form-ing a complex that is hyper-antigenic and inducing complementary antibodies having an idiotype-antiidiotype relationship. Autoim-munity 2001; 33: 153-69.
30. Fuchs U, von Dorsche HH, Ziegler M, Ambrosius H. Anti-glucagon insulitis and A-cell hyperplasia of pancreatic islets. Z Mikrosk Anat Forsch 1988; 102(5): 829-32.
31. Gergely A, Koranyl L, Halmos T, et al. Anti-glucagon antibodies in diabetes mellitus. Ann Immunol Hung 1973; 17: 231-3.
32. Huang X, Miller W. A time-efficient, linear-space local similarity algorithm. Adv Appl Math 1991; 12: 337-57.
33. Codina-Busqueta E, Scholz E, Munoz-Torres PM, et al. TCR bias of in vivo expanded T cells in pancreatic islets and spleen at the on-set in human type 1 diabetes. J Immunol 2011; 186: 3787-97.
34. Shoelson SE, Marshall S, Horikoshi H, KOlterman OG, Rubenstein AH, Olefsky JM. Antiinsulin receptor antibodies in an insulin-dependent diabetic may arise as autoantiidiotypes. J Clin Endocri-nol Metab 1986; 63: 56-61.
35. Shechter YR, Maron D, Cohen IR. Autoantibodies to insulin recep-tor spontaneously develop as anti-idiotypes in mice immunized with insulin. Science 1982; 216: 542-4.
36. Shechter Y, Elias D, Maron R, Cohen IR. Mouse antibodies to the insulin receptor developing spontaneously as antiidiotypes: charac-terization of the antibodies. J Biol Chem 1985; 259: 6411-5.
37. Elias D, Maron R, Cohen IR, Shechter Y. Mouse antibodies to the insulin receptor developing spontaneously as anti-idiotypes: effects on glucose homeostasis and the insulin receptor. J Biol Chem 1984; 259: 6416-9.
38. Ludwig SM, Faiman C, Dean JH. Insulin and insulin-receptor autoantibodies in children with newly diagnosed IDDM before in-sulin therapy. Diabetes 1987; 36: 420-25.
39. Biogps.org. INSR. Available at: http://biogps.org/#goto=genereport&id=3643 Accessed 13 Nov 2012.
40. Poletaev AB, Gnedenko BB, Makarova AA, et al. Possible mecha-nisms of diabetic fetopathy. Hum Antibodies 2000; 9: 189-97.
41. Portsenko AM, Budykina TS, Morozov SG, Rybakov AS, Gribova IE, Protsenko AN. Perinatal outcomes in pregnant women with diabetes mellitus and different level of autoantibodies to insulin and its receptors. Patol Fiziol Eksp Ter 2010; 2: 18-2
42. Li Y, Smith D, Li Q, et al. Antibody-mediated retinal pericyte injury: implications for diabetic retinopathy. Invest Ophthalmol Vis Sci 2012; 53(9): 5520-6.
43. Attawia MA, Nayak RC. Circulating antipericyte autoantibodies in diabetic retinopathy. Retina 1999; 19(5): 390-400.
44. Fujinami RS, Oldstone MB. Molecular mimicry as a mechanism for virus-induced autoimmunity. Immunol Res 1989; 8(1): 3-15.
45. Plotz PH. Autoantibodies are anti-idiotype antibodies to antiviral antibodies. Lancet 1983; 2(8354): 824-6.
46. Root-Bernstein RS. Self, nonself, and the paradoxes of autoimmu-nity. In: Tauber AI, Ed. Organism and the Development of Self. Boston: Kluwer 1991; pp. 159-209.
47. Root-Bernstein R. Antigenic complementarity in the induction of autoimmunity: a general theory and review. Autoimmun Rev 2007; 6(5): 272-7.
48. Root-Bernstein RS, Couturier J. Antigenic complementarity in the origins of autoimmunity: a general theory illustrated with a case study of idiopathic thrombocytopenia purpura. Clin Develop Im-munol 2006; 13: 49-65.
49. Root-Bernstein RS, Vonck J, Podufaly A. Antigenic complemen-tarity between coxsackie virus and streptococci in rheumatic heart disease and myocarditis. Autoimmunity 2009; 22(3): 177-87.
50. Jerne NK. Towards a network theory of the immune system. Ann Immunol 1974; 125C(1-2): 373-89.
51. Tzioufas Ag, Routsias JG. Idiotype, anti-idiotype network of autoantibodies. Pathogenetic considerations and clinical applica-tion. Autoimmun Rev 2010; 9: 63
52. Hampe CS. 2012. Protective role of anti-idiotypic antibodies in autoimmunity - lessons for type 1 diabetes. Autoimmunity 2012; 45: 320-31.
53. Adelman MK, Schluter SF, Robey IF, Marchalonis JJ. Natural and autoantibodies to human T-cell receptor Vbeta segments: po-tential roles in immunomodulation. Crit Rev Immunol 2007; 27(3): 221-32.
54. McGuire KL, Holmes DS. Role of complementary proteins in autoimmunity. Trends Immunol 2005; 26: 367-72.
55. Pendergraft WF, 3RD, Preston GA, Shah RR, et al. Autoimmunity is triggered by cPR-3 (105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 2004; 10: 72-9.
56. Pendergraft WF 3rd, Jennette JC, Ralk RJ, Preston GA. Autoantigen complementarity: a new theory implicating complementary pro-teins as initiators of autoimmune disease. J Mol Med 2005; 83: 12-25.
57. Preston GA, Pendergraft WF 3rd, Falk RJ. New insights that link microbes with the generation of antineutrophil cytoplasmic autoan-tibodies: the theory of autoantigen complementarity. Curr Opin Nephrol Hypertens 2005; 14(3): 217-22.
58. Wooldridge L, Ekeruche-Makinde J, van den Berg HA, et al. A singl autoimmune T cell receptor recognizes more than a million different peptides. J Biol Chem 2012; 287: 1168-77.
59. Ylipaasto P, Smura T, Gopalacharyulu P, et al. Enterovirus-induced gene expression profile is critical for human pancreatic is-let destruction. Diabetologia 2012; 55(12): 3273-83.
60. Rešić LS, Honkanen H, Nix WA, et al. Seroconversion to islet autoantibodies after enterovirus infection in early pregnancy. Viral Immunol 2012; 25(4): 254-61.
61. Christen U, Bender C, von Herrath MG. Infection as a cause of type 1 diabetes? Curr Opin Rheumatol 2012; 24(4): 417-23.